(Q41017632)

25 September 2017

1 reference

title

Atopic dermatitis: an update (English)

1 reference

25 September 2017

1 reference

Rothe MJ

1

1 reference

25 September 2017

Grant-Kels JM

series ordinal

2

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 July 1996

1 reference

Journal of the American Academy of Dermatology

25 September 2017

published in

1 reference

25 September 2017

volume

35

1 reference

25 September 2017

issue

1

1 reference

25 September 2017

page(s)

1-13; quiz 14-6

1 reference

Evaluation of minor clinical features of atopic dermatitis

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Frequency and significance of the major and minor features of Hanifin and Rajka among patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Infraorbital Crease, Ethnic Group, and Atopic Dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Is the prevalence of atopic dermatitis increasing?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

On the definition and epidemiology of atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

The prevalence of childhood atopic eczema in a general population

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Asthma, allergic rhinitis and atopic eczema in Finnish children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Prevalence of atopic disorders among adolescents in Turku, Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Ethnic differences in the pattern of skin disease seen in a dermatology department-atopic dermatitis is more common among Asian referrals in Leicestershire

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Atopic eczema in a multiracial country (Malaysia)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Prevalence of atopic dermatitis in Leicester: a study of methodology and examination of possible ethnic variation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

London-born black Caribbean children are at increased risk of atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Childhood eczema: disease of the advantaged?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Confirmation of genetic linkage between atopic IgE responses and chromosome 11q13

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Chromosome 11 q13 and atopy underlying atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Genetic risk for asthma, allergic rhinitis, and atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Maternal inheritance of atopic IgE responsiveness on chromosome 11q.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Food hypersensitivity and dietary management in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Pathogenesis of atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Atopic dermatitis: triggering factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Immediate- and delayed-type contact hypersensitivity in children older than 5 years with atopic dermatitis: a pilot study comparing different tests

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Dust mite allergens and asthma—A worldwide problem

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Creating optimal home conditions for the house dust mite

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Exposure to house dust mites in homes of people with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Atopic dermatitis and aeroallergen contact sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

The role of dust mite allergens in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Allergen-antibody complexes in the treatment of Dermatophagoides pteronyssinus hypersensitivity diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Patch test reactions to mite antigens: a GERDA multicentre study. Groupe d'Etudes et de Recherches en Dermato-Allergie

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Combination of patch test and IgE for dust mite antigens differentiates 130 patients with atopic dermatitis into four groups

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Allergy Consultation in the Management of Atopic Dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Effect of allergen avoidance in infancy on allergic manifestations at age two years

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Allergy prevention by maternal elimination diet during late pregnancy--a 5-year follow-up of a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

The development and prediction of atopy in high-risk children: follow-up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

A population study of food intolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Prevalence of food allergy and intolerance in the adult Dutch population

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Protein contact dermatitis: myth or reality?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

1 reference

7 January 2021

Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Atopic dermatitis: is it an allergic disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Cord serum IgE: an insensitive method for prediction of atopy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Neonatal IgE: a poor screen for atopic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

High anti-IgE levels at birth are associated with a reduced allergy prevalence in infants at risk: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Peripheral blood eosinophilia in infants at 3 months of age is associated with subsequent development of atopic disease in early childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Appearance of atopic disease in relation to serum IgE antibodies in children followed up from birth for 4 to 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Reduced interferon-gamma secretion in neonates and subsequent atopy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Is deficiency of interferon gamma production by allergen triggered cord blood cells a predictor of atopic eczema?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Analysis of polyunsaturated fatty acids in newborn sera: a screening tool for atopic disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Eosinophil cationic protein in sera of patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Can cyclosporin A induce permanent remission of atopic dermatitis?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Maintenance treatment with cyclosporin in atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Recombinant interferon gamma therapy for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Systemic interferon gamma treatment in severe atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Gamma-interferon therapy for severe cases of atopic dermatitis of the adult type.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Interferon-gamma for treatment of severe atopic eczema in two children

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Alpha-interferon treatment of patient with hyper IgE syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Interferon-alpha for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

A double-blind placebo-controlled study of thymostimulin (TP-1) for the treatment of atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Thymopentin treatment in severe atopic dermatitis--clinical and immunological evaluations

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

A double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of thymopentin as an adjunctive treatment in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Topical corticosteroids and Staphylococcus aureus in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Ranitidine treatment of hand eczema in patients with atopic dermatitis: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Effect of topical cromoglycate solution on atopic dermatitis: combined treatment of sodium cromoglycate solution with the oral anti-allergic medication, oxatomide

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

UVA solarium versus UVB phototherapy of atopic dermatitis: a paired-comparison study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Narrow-band (TL-01) UVB air-conditioned phototherapy for chronic severe adult atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

High-dose UVA1 therapy in the treatment of patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Oral psoralen photochemotherapy in severe childhood atopic eczema: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Atopic dermatitis: studies of skin permeability and effectiveness of topical PUVA treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Tacrolimus ointment for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Psychotherapy for intractable inflammatory dermatoses

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Hypnotherapy as a treatment for atopic dermatitis in adults and children

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

One-year follow up of children treated with Chinese medicinal herbs for atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Follow-up of adult patients with atopic eczema treated with Chinese herbal therapy for 1 year

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

A novel therapy for atopic dermatitis with allergen-antibody complexes: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Allergen-sensitive atopic dermatitis is improved by injections of allergen combined with F(ab')2 fragments of specific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Clinical improvement after unusual avoidance measures in the home of an atopic dermatitis patient

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind, multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

The efficacy and safety of gamma-linolenic acid in the treatment of infantile atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Controlled trial of a few foods diet in severe atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

A role for eosinophils in the pathogenesis of skin lesions in patients with food-sensitive atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

Ten‐year prognosis for generalized infantile eczema

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

[Sites, types of manifestations and micromanifestations of atopic dermatitis in young adults. A personal follow-up 20 years after diagnosis in childhood]

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990486-7

7 January 2021

10.1016/S0190-9622(96)90486-7

Identifiers

DOI

1 reference

25 September 2017

1 reference